Time from symptoms onset to remdesivir is associated with the risk of ICU admission: a multicentric analyses

por Alonso-Navarro, Rodrigo, Ramírez, Margarita, Masiá, Mar, Paredes, Roger, Montejano, Rocío, Povar-Echeverria, Marina, Carratalà, Jordi, Salavert, Miguel, Bernal, Enrique, Dueñas, Carlos, Flores, Juan, Fanjul, Francisco, Gutiérrez, Isabel, Rico, Verónica, Mateu, Lourdes, Cadiñanos, Julen, Berenguer, Juan, Soriano, Alex
Publicado 2023

Real-life use of remdesivir in hospitalized patients with COVID-19

por Garcia-Vidal, Carolina, Meira, Fernanda, Cózar-Llistó, Alberto, Dueñas, Gerard, Puerta-Alcalde, Pedro, Garcia-Pouton, Nicole, Chumbita, Mariana, Cardozo, Celia, Hernandez-Meneses, Marta, Alonso-Navarro, Rodrigo, Rico, Verónica, Agüero, Daiana, Bodro, Marta, Morata, Laura, Jordan, Carlota, Lopera, Carlos, Ambrosioni, Juan, Segui, Ferran, Grafia, Nacho, Castro, Pedro, García, Felipe, Mensa, Josep, Martínez, José Antonio, Sanjuan, Gemma, Soriano, Alex
Publicado 2021